Aptamer-based technology for gastric cancer theranostics.

Area of Science:

• Biomedical research
• Molecular oncology
• Biotechnology

Background:

• Gastric cancer is a leading cause of cancer mortality globally.
• High molecular and phenotypic heterogeneity complicates treatment.
• Late-stage diagnosis leads to poor survival rates, emphasizing the need for early detection.

Purpose of the Study:

• To review aptamer enrichment and evolution for gastric cancer.
• To document recent advancements in aptamer-based diagnostics and therapeutics.
• To highlight the potential of aptamer technology in combating gastric cancer.

Main Methods:

• Literature review of aptamer selection techniques (e.g., SELEX).
• Analysis of current aptamer-based diagnostic assays for gastric cancer biomarkers.
• Review of aptamer-mediated targeted therapy strategies.

Main Results:

• Aptamers have been successfully developed for various gastric cancer biomarkers.
• Emerging aptamer-based methods show potential for sensitive and specific early detection.
• Aptamers are being explored for targeted drug delivery and therapeutic applications.

Conclusions:

• Aptamer technology offers a promising avenue for early gastric cancer diagnosis.
• Aptamer-based approaches can facilitate precision therapy for gastric cancer patients.
• Further research is needed to translate aptamer technology into clinical practice.